/Companies

TIXiMED

Birmingham, US · Founded 2021 · Delaware corporation

Find your way into TIXiMED

Sign up to see every warm intro you have to TIXiMED

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the TIXiMED team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

TM
Thomas Michael Goodrich IIExecutive

Board

AS
Aneth ShalevBoard director

Reported raises · per SEC filings

Form D private placements

$550K disclosed across 1 of 2 rounds · 2024–2026

▶$550KraisedNov 2024 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas Michael Goodrich IIExecutive Officer, Director
  • Aneth ShalevDirector
Offering amount
$550K
Amount sold
$550K
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has TIXiMED raised?
TIXiMED has disclosed $550K raised across 1 of its 2 known rounds.
Where is TIXiMED headquartered?
TIXiMED is headquartered in Birmingham, US.